These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 20699371)

  • 21. Serum insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and risk of breast cancer in the Japan Collaborative Cohort study.
    Sakauchi F; Nojima M; Mori M; Wakai K; Suzuki S; Tamakoshi A; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():51-5. PubMed ID: 20553082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.
    Cao Y; Nimptsch K; Shui IM; Platz EA; Wu K; Pollak MN; Kenfield SA; Stampfer MJ; Giovannucci EL
    Int J Cancer; 2015 May; 136(10):2418-26. PubMed ID: 25348852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Chia D; Crawford ED; Kaaks R; Hayes RB
    Int J Cancer; 2007 Nov; 121(10):2267-73. PubMed ID: 17597108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
    Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
    J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Peeters PH; Lukanova A; Allen N; Berrino F; Key T; Dossus L; Rinaldi S; van Gils CH; Bueno-de-Mesquita HB; Boeing H; Schulz M; Chang-Claude J; Linseisen J; Panico S; Sacerdote C; Palli D; Tumino R; Trichopoulou A; Trichopolos D; Bamia C; Larranaga N; Ardanaz E; Pera G; Quirós JR; Martínez-García C; Navarro C; Bingham SA; Khaw KT; Clavel F; Tjonneland A; Olsen A; Overvad K; Tetsche MS; Lund E; Lundin E; Berglund G; Riboli E; Kaaks R
    Endocr Relat Cancer; 2007 Mar; 14(1):81-90. PubMed ID: 17395977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai.
    Probst-Hensch NM; Yuan JM; Stanczyk FZ; Gao YT; Ross RK; Yu MC
    Br J Cancer; 2001 Nov; 85(11):1695-9. PubMed ID: 11742490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
    Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
    Cancer Res; 2007 Aug; 67(16):7923-8. PubMed ID: 17699799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.
    Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP
    Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
    Drogan D; Schulze MB; Boeing H; Pischon T
    Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort.
    Gill JK; Wilkens LR; Pollak MN; Stanczyk FZ; Kolonel LN
    Prostate; 2010 Jun; 70(8):906-15. PubMed ID: 20166103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.
    Roddam AW; Allen NE; Appleby P; Key TJ; Ferrucci L; Carter HB; Metter EJ; Chen C; Weiss NS; Fitzpatrick A; Hsing AW; Lacey JV; Helzlsouer K; Rinaldi S; Riboli E; Kaaks R; Janssen JA; Wildhagen MF; Schröder FH; Platz EA; Pollak M; Giovannucci E; Schaefer C; Quesenberry CP; Vogelman JH; Severi G; English DR; Giles GG; Stattin P; Hallmans G; Johansson M; Chan JM; Gann P; Oliver SE; Holly JM; Donovan J; Meyer F; Bairati I; Galan P
    Ann Intern Med; 2008 Oct; 149(7):461-71, W83-8. PubMed ID: 18838726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China.
    London SJ; Yuan JM; Travlos GS; Gao YT; Wilson RE; Ross RK; Yu MC
    J Natl Cancer Inst; 2002 May; 94(10):749-54. PubMed ID: 12011225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosis.
    Mu F; Hankinson SE; Schernhammer E; Pollak MN; Missmer SA
    Am J Epidemiol; 2015 Jul; 182(2):148-56. PubMed ID: 26121987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.
    Miles FL; Goodman PJ; Tangen C; Torkko KC; Schenk JM; Song X; Pollak M; Thompson IM; Neuhouser ML
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28417914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.